Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 20/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5728623 | 1.00 | ELANE (0.71) | ELANE | |
| SCHEMBL9585729 | 0.90 | ELANE (0.88) | ELANE | |
| SCHEMBL5728701 | 0.86 | ELANE (0.64) | ELANE | |
| SCHEMBL6110027 | 0.85 | ELANE (0.57) | ELANE | |
| SCHEMBL6110034 | 0.85 | ELANE (0.57) | ELANE | |
| SCHEMBL7399121 | 0.83 | ELANE (0.73) | ELANE | |
| Hydrochloric Acid SCHEMBL5728196 | 0.83 | ELANE (0.68) | ELANE | |
| Hydrochloric Acid SCHEMBL5728182 | 0.83 | ELANE (0.68) | ELANE | |
| SCHEMBL9584066 | 0.83 | ELANE (0.65) | ELANE | |
| SCHEMBL9585108 | 0.83 | ELANE (0.84) | ELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060270850-A1 | Processes for preparation of pyrimidine derivatives and intermediates | AJINOMOTO CO., INC. (JP) | 2006-11-30 | — | — | US | disclosed |
| EP-1695967-A1 | PROCESSES FOR PRODUCTION OF PYRIMIDINE DERIVATIVES AND INTERMEDIATES | Ajinomoto Co., Inc. (JP) | 2006-08-30 | — | — | EP | disclosed |
| US-20050176966-A1 | Process for the preparation of pyrimidine derivative, intermediate therefor and process for the preparation thereof | AJINOMOTO CO., INC. (JP) | 2005-08-11 | — | — | US | disclosed |
| EP-1529778-A1 | Production method of pyrimidine derivative, intermediate therefor | Ajinomoto Co., Inc. (JP) | 2005-05-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050176966-A1 | Process for the preparation of pyrimidine derivative, intermediate therefor and process for the preparation thereof | DPYD, WEE1, DCXR | ELANE 4520/4885 |
| US-20060270850-A1 | Processes for preparation of pyrimidine derivatives and intermediates | PDXK, RNASEL, DPYD | ELANE 4219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.